Prediagnostic plasma testosterone, sex hormone-binding globulin, IGF-I and hepatocellular carcinoma: etiological factors or risk markers?
Elevated prediagnostic testosterone and insulin-like growth factor I (IGF-I) concentrations have been proposed to increase risk of hepatocellular carcinoma (HCC). However, the metabolism of these hormones is altered as a consequence of liver damage and they may have clinical utility as HCC risk mark...
Main Authors: | Lukanova, A, Becker, S, Hüsing, A, Schock, H, Fedirko, V, Trepo, E, Trichopoulou, A, Bamia, C, Lagiou, P, Benetou, V, Trichopoulos, D, Nöthlings, U, Tjønneland, A, Overvad, K, Dossus, L, Teucher, B, Boeing, H, Aleksandrova, K, Palli, D, Pala, V, Panico, S, Tumino, R, Ricceri, F, Bueno-de-Mesquita, H, Siersema, P |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
2014
|
Títulos similares
-
Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations.
por: Fedirko, V, et al.
Publicado: (2012) -
Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study.
por: Fedirko, V, et al.
Publicado: (2014) -
Prediagnostic circulating parathyroid hormone concentration and colorectal cancer in the European Prospective Investigation into Cancer and Nutrition cohort.
por: Fedirko, V, et al.
Publicado: (2011) -
Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer
por: Aleksandrova, K, et al.
Publicado: (2014) -
Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer.
por: Aleksandrova, K, et al.
Publicado: (2014)